ANTI-G(M3) (II(3)NEU5AC-LACTOSYLCERAMIDE) GANGLIOSIDE ANTIBODY LABELSHUMAN FETAL PURKINJE NEURONS DURING THE CRITICAL STAGE OF CEREBELLAR DEVELOPMENT

Citation
M. Hefferlauc et al., ANTI-G(M3) (II(3)NEU5AC-LACTOSYLCERAMIDE) GANGLIOSIDE ANTIBODY LABELSHUMAN FETAL PURKINJE NEURONS DURING THE CRITICAL STAGE OF CEREBELLAR DEVELOPMENT, Neuroscience letters, 213(2), 1996, pp. 91-94
Citations number
17
Categorie Soggetti
Neurosciences
Journal title
ISSN journal
03043940
Volume
213
Issue
2
Year of publication
1996
Pages
91 - 94
Database
ISI
SICI code
0304-3940(1996)213:2<91:A(GAL>2.0.ZU;2-T
Abstract
The ganglioside G(M3) (II(3)Neu5Ac-lactosylceramide) represents a mino r ganglioside in normal human brain compared to major gangliosides wit h gangliotetraose-backbone. In this study the presence of G(M3) in thr ee 23 and 24 weeks of gestation old human cerebella was demonstrated b y immunostaining extracted gangliosides on thin-layer chromatography p late as well as by immunohistochemical analysis of cerebellar cryosect ions. During this stage of brain development G(M3) was found to be dom inantly expressed on cells corresponding to Purkinje neurons. Delipida tion of histological sections with chloroform/methanol caused signific ant reduction of anti-G(M3) immunostaining, thus confirming the preval ent ganglioside nature of this antigen. These results give evidence th at (1) G(M3) ganglioside is associated with a specific subset of human fetal cerebellar neurons during the critical developmental stage, and (2) a definite ganglioside in general is distributed to a specific su bset of cells in normal human brain.